Brief: Immunovia Resolves On Rights Issue Of About SEK 202.2 Million

Immunovia AB (publ)

20/02/2023 07:16

Feb 20 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY SEK
202.2
MILLION AND POSTPONES THE PUBLICATION OF THE QUARTERLY REPORT
FOR THE FIRST QUARTER AND THE ANNUAL GENERAL MEETING
    * RECEIVED SUBSCRIPTION COMMITMENTS, SUBSCRIPTION INTENTIONS
AND
GUARANTEE COMMITMENTS FOR A TOTAL OF SEK 151.8 MILLION,
CORRESPONDING TO APPROXIMATELY 75 PERCENT OF RIGHTS ISSUE
    * PURPOSE OF RIGHTS ISSUE IS TO ACCELERATE COMMERCIAL
ROLLOUT OF
IMMRAY® PANCAN-D, INVEST IN RESEARCH AND DEVELOPMENT AND
STRENGTHEN ONGOING BUSINESS OPERATIONS
    * SUBSCRIPTION PERIOD WILL RUN FROM AND INCLUDING 23 MARCH
2023 TO
AND INCLUDING 6 APRIL 2023

Source text for Eikon:  ID:nWkr5WQh1B 
Further company coverage:  IMMNOV.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))